Navigation Links
BioHorizons Announces Agreement to Purchase Implant Logic Systems
Date:1/30/2008

BIRMINGHAM, Ala., and CEDARHURST, N.Y., Jan 30 /PRNewswire/ -- BioHorizons Implant Systems, Inc. ("BioHorizons") announced today its parent company has entered into a definitive agreement to purchase Implant Logic Systems, Ltd. ("ILS"). ILS is a leading innovator and provider of technology solutions for the implant dentistry market. ILS's Virtual Implant Placement software enables implantologists to view CT scans and create virtual implant treatment plans. Implantologists can then use ILS's Compu-Guide system to create custom milled surgical guides that bring the virtual treatment plan into the operating suite. Terms of the transaction were not disclosed.

"We are thrilled to add the technology and expertise of ILS to BioHorizons," stated R. Steven Boggan, President and CEO of BioHorizons. "Our customers have expressed great interest in computer assisted implant treatment planning software and surgical guides. ILS perfectly addresses this customer need. In addition, the Compu-Guide surgical guide system is designed to allow the clinician to place implants more accurately, more quickly and more safely than is otherwise possible. The acquisition of ILS will create significant value for our customers."

Dr. Michael Klein, President and CEO of ILS, stated, "We are excited about the opportunity to join with BioHorizons. ILS is already well known for its implant planning software and innovative computer guided surgical tools, but our customers will now get the expanded benefits of working with BioHorizons, one of the most progressive and customer-centric companies in the industry."

For More Information:

Steve Boggan

President and CEO of BioHorizons

205.967.7880

About Implant Logic Systems

Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Implant Logic Systems operates in the fields of software technology and medical devices to create a revolutionary implant placement technique. This technique is intended to be less invasive to the patient, shorten recovery time, reduce surgery time by up to 75%, and provide a more accurate implant placement. Implant Logic Systems has experienced rapid growth over the past several years. Implant Logic Systems' computer guided system has proven itself in thousands of clinical surgeries.

http://www.implantlogic.com

About BioHorizons

With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. The company has a broad product offering of dental implants including Tapered Internal, Single-stage, Internal, External, One-piece 3.0, and Overdenture. BioHorizons has exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. The company has a direct sales force in the U.S., Canada, Germany, Spain, United Kingdom, Australia, Mexico, and Chile. Products are distributed in the rest of the world via a network of independent distributors. The Company was purchased by HealthpointCapital in 2006.

http://www.biohorizons.com


'/>"/>
SOURCE BioHorizons Implant Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... International, a not-for-profit organization focused on the ethics and governance ... to patients around the world, today announced that the editors ... the Good Pharma Scorecard an ,Editors, Pick, ... of BMJ Open ,s ,Most Popular Articles, which includes ... read. Ed Sucksmith , assistant editor of ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... focused on the development and manufacture of biopharmaceuticals and therapeutics, announces an ... the 2016 BioProcess International Awards – Recognizing Excellence in the People, Organizations ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of its new stem cell treatment clinic in Quito, Ecuador. The new facility ... and trauma applications to patients from around the world. , The new ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
Breaking Biology News(10 mins):